CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults [Phase 2, Phase 3]
Summary
Pfizer completed Phase 2 and Phase 3 trials evaluating rimegepant for migraine prevention in adults, with results posted in August 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-09